Jazz Pharmaceuticals plc (JAZZ) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $128.50M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $128.50M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $128.50M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Obligation categories | (m) |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $128.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $140.90M | (m) |
| 2026-03-31 | (m) | $100.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $161.50M | (m) |
| 2025-12-31 | (m) | $122.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $124.52M | (m) |
| 2025-09-30 | (m) | $152.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $108.91M | (m) |
| 2025-06-30 | (m) | $89.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $93.73M | (m) |
| 2025-03-31 | (m) | $95.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $91.12M | (m) |
| 2024-12-31 | (m) | $77.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $86.61M | (m) |
| 2024-09-30 | (m) | $85.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $110.97M | (m) |
| 2024-06-30 | (m) | $97.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $99.42M | (m) |
| 2024-03-31 | (m) | $80.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $97.42M | (m) |
| 2023-12-31 | (m) | $102.75M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | $104.75M | (m) |
| 2023-09-30 | (m) | $109.85M | (m) | (m) | (m) | (m) | (m) | $4.00K | (m) | $127.48M | (m) |
| 2023-06-30 | (m) | $98.43M | (m) | (m) | (m) | (m) | (m) | $4.00K | (m) | $126.68M | (m) |
| 2023-03-31 | (m) | $125.45M | (m) | (m) | (m) | (m) | (m) | $4.00K | (m) | $109.18M | (m) |
| 2022-12-31 | (m) | $90.76M | $463.00K | (m) | $106.81M | (m) | (m) | $463.00K | $0.00 | $106.81M | $0.00 |
| 2022-09-30 | (m) | $102.25M | $987.00K | (m) | $123.94M | (m) | (m) | $871.00K | $116.00K | $123.94M | $0.00 |
| 2022-06-30 | (m) | $74.16M | $1.51M | (m) | $129.42M | (m) | (m) | $1.28M | $231.00K | $129.42M | $0.00 |
| 2022-03-31 | (m) | $73.34M | $2.03M | (m) | $124.64M | (m) | (m) | $1.69M | $347.00K | $124.64M | $0.00 |
| 2021-12-31 | (m) | $100.30M | $2.56M | (m) | $117.00M | (m) | (m) | $2.09M | $463.00K | $117.00M | $0.00 |
| 2021-09-30 | (m) | $63.81M | $3.25M | (m) | $137.81M | (m) | (m) | $2.27M | $986.00K | $137.81M | $0.00 |
| 2021-06-30 | (m) | $64.83M | $3.95M | (m) | $132.51M | (m) | (m) | $2.44M | $1.51M | $132.51M | $0.00 |
| 2021-03-31 | (m) | $77.74M | $4.22M | (m) | $105.87M | (m) | (m) | $2.37M | $1.85M | $105.87M | $0.00 |
| 2020-12-31 | (m) | $26.95M | $4.86M | (m) | $101.15M | (m) | (m) | $2.55M | $2.31M | $101.15M | $0.00 |
| 2020-09-30 | (m) | $67.06M | $6.04M | (m) | $142.47M | (m) | (m) | $3.09M | $2.95M | $142.47M | $0.00 |
| 2020-06-30 | (m) | $50.04M | $7.22M | (m) | $134.84M | (m) | (m) | $3.63M | $3.59M | $134.84M | $0.00 |
| 2020-03-31 | (m) | $66.31M | $8.40M | (m) | $117.26M | (m) | (m) | $4.18M | $4.22M | $117.26M | $0.00 |
| 2019-12-31 | (m) | $47.55M | $9.58M | (m) | $109.37M | (m) | (m) | $4.72M | $4.86M | $109.37M | $0.00 |
| 2019-09-30 | (m) | $70.10M | $10.76M | (m) | $102.58M | (m) | (m) | $4.72M | $6.04M | $102.58M | $0.00 |
| 2019-06-30 | (m) | $82.22M | $11.94M | (m) | $120.71M | (m) | (m) | $4.72M | $7.22M | $120.71M | $0.00 |
| 2019-03-31 | (m) | $42.67M | $13.12M | (m) | $111.90M | (m) | (m) | $4.72M | $8.40M | $111.90M | $0.00 |
| 2019-01-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $105.26M | (m) |
| 2018-12-31 | (m) | $40.60M | $14.99M | (m) | $218.88M | (m) | (m) | $5.41M | $9.58M | $218.88M | $0.00 |
| 2018-09-30 | (m) | $37.37M | $16.87M | (m) | $208.65M | (m) | (m) | $5.93M | $10.93M | $208.65M | $0.00 |
| 2018-06-30 | (m) | $31.38M | $18.74M | (m) | $205.73M | (m) | (m) | $6.46M | $12.29M | $205.73M | $0.00 |
| 2018-03-31 | (m) | $46.93M | $20.62M | (m) | $192.18M | (m) | (m) | $6.98M | $13.64M | $192.18M | $0.00 |
| 2018-01-01 | (m) | (m) | $22.49M | (m) | (m) | (m) | (m) | $7.50M | $14.99M | (m) | $0.00 |
| 2017-12-31 | (m) | $24.37M | $24.73M | (m) | $176.61M | (m) | (m) | $8.62M | $16.11M | $176.61M | $0.00 |
| 2017-09-30 | (m) | $29.97M | $26.89M | (m) | $158.50M | (m) | (m) | $8.62M | $18.27M | $158.50M | $0.00 |
| 2017-06-30 | (m) | $28.53M | $29.05M | (m) | $144.69M | (m) | (m) | $8.57M | $20.47M | $144.69M | $0.00 |
| 2017-03-31 | (m) | $29.14M | $31.21M | (m) | $128.81M | (m) | (m) | $8.59M | $22.62M | $128.81M | $0.00 |
| 2016-12-31 | (m) | $22.41M | $3.72M | (m) | $112.62M | (m) | (m) | $1.12M | $2.60M | $112.62M | $0.00 |
| 2016-09-30 | (m) | $17.63M | $4.38M | (m) | $106.10M | (m) | (m) | $1.50M | $2.88M | $106.10M | $0.00 |
| 2016-06-30 | (m) | $28.41M | $4.59M | (m) | $94.20M | (m) | (m) | $1.43M | $3.16M | $94.20M | $0.00 |
| 2016-03-31 | (m) | $32.62M | $4.82M | (m) | $79.21M | (m) | (m) | $1.38M | $3.44M | $79.21M | $0.00 |
| 2015-12-31 | (m) | $21.81M | $5.09M | (m) | $69.25M | (m) | (m) | $1.37M | $3.72M | $69.25M | $0.00 |
| 2015-09-30 | (m) | $29.12M | $4.98M | (m) | $59.67M | (m) | (m) | $1.33M | $3.65M | $59.67M | $0.00 |
| 2015-06-30 | (m) | $26.41M | $5.26M | (m) | $52.66M | (m) | (m) | $1.33M | $3.93M | $52.66M | $0.00 |
| 2015-03-31 | (m) | $27.32M | $5.35M | (m) | $45.12M | (m) | (m) | $1.14M | $4.21M | $45.12M | $0.00 |
| 2014-12-31 | (m) | $25.13M | $5.64M | (m) | $38.39M | (m) | (m) | $1.14M | $4.50M | $38.39M | $0.00 |
| 2014-09-30 | (m) | $29.67M | $5.92M | (m) | $33.60M | (m) | (m) | $1.14M | $4.78M | $33.60M | $0.00 |
| 2014-06-30 | (m) | $32.55M | $6.29M | (m) | $29.18M | (m) | (m) | $1.14M | $5.15M | $29.18M | $0.00 |
| 2014-03-31 | (m) | $72.54M | $6.57M | (m) | $25.39M | (m) | (m) | $1.14M | $5.43M | $25.39M | $0.00 |
| 2013-12-31 | (m) | $21.00M | $6.86M | (m) | $20.04M | (m) | (m) | $1.14M | $5.72M | $20.04M | $0.00 |
| 2013-09-30 | (m) | $22.43M | $7.14M | (m) | $16.75M | (m) | (m) | $1.14M | $6.00M | $16.75M | $0.00 |
| 2013-06-30 | (m) | $20.37M | $7.42M | (m) | $13.33M | (m) | (m) | $1.14M | $6.28M | $13.33M | $0.00 |
| 2013-03-31 | (m) | $31.63M | $7.70M | (m) | $9.82M | (m) | (m) | $1.14M | $6.57M | $9.82M | $0.00 |
| 2012-12-31 | (m) | $15.89M | $7.91M | (m) | $6.62M | (m) | (m) | $1.14M | $6.78M | $6.62M | $0.00 |
| 2012-09-30 | (m) | $20.54M | $9.07M | (m) | $2.16M | (m) | (m) | $1.94M | $7.13M | $2.16M | $0.00 |
| 2012-06-30 | (m) | $34.51M | $9.37M | (m) | $1.61M | (m) | (m) | $2.01M | $7.36M | $1.61M | $0.00 |
| 2012-03-31 | (m) | $13.69M | $8.77M | (m) | $1.31M | (m) | (m) | $1.14M | $7.63M | $1.31M | $0.00 |
| 2011-12-31 | (m) | $5.13M | $9.05M | (m) | (m) | (m) | (m) | $1.14M | $7.92M | (m) | $0.00 |
| 2011-09-30 | (m) | $8.46M | $9.34M | (m) | (m) | (m) | (m) | $1.14M | $8.20M | (m) | $0.00 |
| 2011-06-30 | (m) | $4.67M | $9.85M | (m) | (m) | (m) | (m) | $1.37M | $8.48M | (m) | $0.00 |
| 2010-12-31 | (m) | $3.05M | $10.33M | (m) | (m) | (m) | (m) | $1.27M | $9.05M | (m) | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |